- Home
- MDGL vs HRL Comparison
MDGL vs HRL Comparison
Compare MDGL & HRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | HRL |
|---|---|---|
| Founded | 2011 | 1891 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Meat/Poultry/Fish |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1B | 11.8B |
| IPO Year | 2005 | 1994 |
Fundamental Metrics
Financial Performance| Metric | MDGL | HRL |
|---|---|---|
| Price | $517.09 | $21.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 6 |
| Target Price | ★ $674.45 | $26.50 |
| AVG Volume (30 Days) | 261.6K | ★ 4.3M |
| Earning Date | 05-06-2026 | 05-28-2026 |
| Dividend Yield | N/A | ★ 5.61% |
| EPS Growth | ★ 41.32 | N/A |
| EPS | N/A | ★ 0.33 |
| Revenue | $180,133,000.00 | ★ $12,106,160,000.00 |
| Revenue This Year | $58.39 | $2.66 |
| Revenue Next Year | $48.55 | $1.62 |
| P/E Ratio | ★ N/A | $63.38 |
| Revenue Growth | N/A | ★ 1.55 |
| 52 Week Low | $265.00 | $20.32 |
| 52 Week High | $615.00 | $31.43 |
Technical Indicators
Market Signals| Indicator | MDGL | HRL |
|---|---|---|
| Relative Strength Index (RSI) | 54.72 | 43.77 |
| Support Level | $503.93 | $21.03 |
| Resistance Level | $539.17 | $24.62 |
| Average True Range (ATR) | 15.73 | 0.46 |
| MACD | -3.35 | 0.09 |
| Stochastic Oscillator | 46.03 | 56.14 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About HRL Hormel Foods Corporation
Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and became a branded food company. The firm sells its wares through multiple channels, including US retail (61.6% of fiscal 2025 sales), US foodservice (32.6%), and international (5.9%). By product, 73% of fiscal 2025 sales were from perishable food and 27% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.